Showing results (171-180 of 364) with videos related to
Sort By:
Pageof 37
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1980
[Immune monitoring of the cancer patient: suppressor cells and NK cells]A Goutner, Y Thomas, R Huchet, et al.European Journal of Haematology|April 1, 1988
Resistance of some leukemic blasts to lysis by lymphokine activated killer (LAK) cellsP Panayotides, A Porwit, A M Sjögren, et al.Biochemical and Biophysical Research Communications|October 15, 1991
Formation and proliferative effects of lipoxins in human bone marrowL Stenke, M Mansour, C Edenius, et al.Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
4'-O-tetrahydropyranyl adriamycin (THP-ADM)-induced modifications of murine peritoneal macrophagesA Bravo-Cuellar, G Mathé, S Orbach-ArbouysScandinavian Journal of Haematology|October 1, 1986
Specificity and diagnostic implications of the reactivity pattern of a panel of monoclonal antibodies against myeloid leukemia cellsR B Andreasen, P Biberfeld, A Ost, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
Relationship between proliferative activity of bone marrow micrometastasis and plasmatic level of a new cancer marker: lipid associated sialic acid (LASA) in human breast cancerM Ginsbourg, M Musset, J L Misset, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 17, 2002
II. Glutamine and glutamateH Tapiero, G Mathé, P Couvreur, et al.Cancer Treatment Reports|April 1, 1983
Phase II clinical evaluation of 4'-epi-doxorubicinP Hurteloup, P Cappelaere, J P Armand, et al.Cellular Immunology|October 15, 1983
Reversal of immunological tolerance by aclacinomycin through inhibition of suppressor cell activityS Orbach-Arbouys, C E Andrade-Mena, G MathéBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1988
Hematon: a multicellular functional unit in primary hematopoiesisI Blazsek, J L Misset, M Comisso, et al.Pageof 37